Atovaquone is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Prevention of Pneumocystis in pts who are intolerant to TMP-SMX.
  • Oral treatment of mild-to-moderate
  • Atovaquone in combination with proguanil indicated for the prevention and treatment of malaria due to Plasmodium falciparum (including chloroquine-resistant strains) in adults and pediatric pts weighing 5-11 kg.

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: December 22, 2011

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Atovaquone ID - 545015 A1 - Pham,Paul,Pharm.D. AU - Bartlett,John,M.D. Y1 - 2011/12/22/ PB - Johns Hopkins HIV Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545015/all/Atovaquone ER -